Actively Recruiting

Age: 18Years +
All Genders
NCT06171958

Incidence of Acute Kidney Injury After Administration of Iodine Contrast Media in Patients With Reduced Renal Function

Led by Uppsala University · Updated on 2024-05-20

400

Participants Needed

1

Research Sites

101 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is examining if injection of iodine contrast media increases the risk of acute kidney injury in patients with severely reduced renal function. All patients who have a medical need for a computerized tomography, either with or without iodine contrast media, and has a renal function of less than estimated glomerular filtration rate (eGFR) 30 will be recruited. Blood and urine samples will be collected at baseline, three and 21 days after the computerized tomography. Additionally, we will examine if the decision to use iodine contrast media or not was easy or difficult if the use of iodine contrast media potentially changed the patient care and if it might have been lifesaving.

CONDITIONS

Official Title

Incidence of Acute Kidney Injury After Administration of Iodine Contrast Media in Patients With Reduced Renal Function

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • eGFR less than 30 mL/min/1.73m2 calculated using the revised Lund-Malm�f6 formula and plasma creatinine
  • Medical need for either an iodine contrast media (ICM)-enhanced or unenhanced computerized tomography (CT) scan
Not Eligible

You will not qualify if you...

  • Under 18 years of age
  • Receiving ongoing renal replacement therapy
  • Currently treated with nephrotoxic drugs including acyclovir, aminoglycosides, ciclosporins, cisplatin, methotrexate, non-steroidal anti-inflammatory drugs (except low-dose aspirin), or intravenous vancomycin
  • Known allergy to iodine contrast media without receiving prophylactic treatment (for patients in the ICM group)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Uppsala University

Uppsala, Sweden, 751 85

Actively Recruiting

Loading map...

Research Team

F

Felix B Berglund, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here